Anthem Biosciences Limited (NSE:ANTHEM)

India flag India · Delayed Price · Currency is INR
822.70
-23.25 (-2.75%)
At close: Aug 22, 2025, 3:30 PM IST
-2.75%
Market Cap462.15B
Revenue (ttm)20.52B
Net Income (ttm)5.05B
Shares Out561.61M
EPS (ttm)8.99
PE Ratio91.55
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume63,414
Average Volume180,023
Open845.00
Previous Close845.95
Day's Range812.50 - 850.90
52-Week Range570.00 - 857.00
Betan/a
RSI72.76
Earnings DateAug 13, 2025

About Anthem Biosciences

Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the concept stage; preclinical development; and manufacturing development batches of molecules used for clinical Phase I, II, and III trials up to commercial... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 1,825
Stock Exchange National Stock Exchange of India
Ticker Symbol ANTHEM
Full Company Profile

Financial Performance

In 2024, Anthem Biosciences's revenue was 18.50 billion, an increase of 30.29% compared to the previous year's 14.20 billion. Earnings were 4.51 billion, an increase of 22.86%.

Financial Statements

News

There is no news available yet.